<li>abciximab<p>warfarin, abciximab.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>allopurinol<p>allopurinol increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>amiodarone<p>amiodarone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>amobarbital<p>amobarbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>anagrelide<p>warfarin, anagrelide.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>antithrombin alfa<p>antithrombin alfa and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>antithrombin iii<p>antithrombin iii and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>argatroban<p>argatroban and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>azithromycin<p>azithromycin increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>bazedoxifene/conjugated estrogens<p>bazedoxifene/conjugated estrogens decreases effects of warfarin by pharmacodynamic antagonism. Contraindicated. Risk of thromboembolic disorders.</p></li><li>bemiparin<p>bemiparin and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>bezafibrate<p>bezafibrate increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.<span><br><br></span>bezafibrate increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>bivalirudin<p>bivalirudin and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>butabarbital<p>butabarbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>butalbital<p>butalbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>capecitabine<p>capecitabine increases effects of warfarin by unspecified interaction mechanism. Avoid or Use Alternate Drug. Monitor INR and prothrombin time.</p></li><li>carbamazepine<p>carbamazepine will decrease the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.</p></li><li>cefamandole<p>cefamandole increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.</p></li><li>cefazolin<p>cefazolin increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.</p></li><li>cefdinir<p>cefdinir increases effects of warfarin by anticoagulation. Avoid or Use Alternate Drug. cephalosporins may decrease prothrombin activity.</p></li><li>cefditoren<p>cefditoren increases effects of warfarin by anticoagulation. Avoid or Use Alternate Drug. cephalosporins may decrease prothrombin activity.</p></li><li>cefotetan<p>cefotetan increases effects of warfarin by anticoagulation. Avoid or Use Alternate Drug. cephalosporins may decrease prothrombin activity.</p></li><li>cefoxitin<p>cefoxitin will increase the level or effect of warfarin by  Other (see comment). Avoid or Use Alternate Drug. Decr vitamin K-producing intestinal flora may increase INR after a few days.<span><br><br></span>cefoxitin increases effects of warfarin by anticoagulation. Avoid or Use Alternate Drug. cephalosporins may decrease prothrombin activity.</p></li><li>cefpodoxime<p>cefpodoxime will increase the level or effect of warfarin by  anticoagulation. Avoid or Use Alternate Drug. cephalosporins may decrease prothrombin activity</p></li><li>ceftriaxone<p>ceftriaxone increases effects of warfarin by anticoagulation. Avoid or Use Alternate Drug. cephalosporins may decrease prothrombin activity.</p></li><li>cefuroxime<p>cefuroxime will increase the level or effect of warfarin by  anticoagulation. Avoid or Use Alternate Drug. cephalosporins may decrease prothrombin activity</p></li><li>ceritinib<p>ceritinib increases levels of warfarin by affecting hepatic enzyme CYP2C9/10 metabolism. Avoid or Use Alternate Drug. Avoid concurrent use of CYP2C9 substrates known to have narrow therapeutic indices or substrates primarily metabolized by CYP2C9 during treatment with ceritinib; if use of these medications is unavoidable, consider dose.</p></li><li>chloral hydrate<p>chloral hydrate increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>chloramphenicol<p>chloramphenicol increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>cilostazol<p>warfarin, cilostazol.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>cimetidine<p>cimetidine will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.</p></li><li>ciprofibrate<p>ciprofibrate increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.<span><br><br></span>ciprofibrate increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>ciprofloxacin<p>ciprofloxacin will increase the level or effect of warfarin by  affecting hepatic enzyme CYP1A2 metabolism. Avoid or Use Alternate Drug. Quinolone antibiotics such as ciprofloxacin may enhance the anticoagulant effects of warfarin.  Important to monitor INR/prothrombin time and toxic effects of warfarin. Patients receiving this combination should be closely monitored for adverse effects. </p></li><li>clarithromycin<p>clarithromycin increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>clotrimazole<p>clotrimazole increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>conjugated estrogens<p>conjugated estrogens decreases effects of warfarin by pharmacodynamic antagonism. Contraindicated. Risk of thromboembolic disorders.</p></li><li>dabigatran<p>dabigatran and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug. Both drugs have the potential to cause bleeding. Concomitant use may increase risk of bleeding.</p></li><li>dabrafenib<p>dabrafenib will decrease the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Dabrafenib induces CYP3A4 and possibly other enzymes including CYP2C9 that affect warfarin metabolism</p></li><li>dalteparin<p>dalteparin and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>danazol<p>danazol increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>dipyridamole<p>warfarin, dipyridamole.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>duloxetine<p>duloxetine increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>edoxaban<p>edoxaban, warfarin.
Either increases toxicity of the other by anticoagulation. Avoid or Use Alternate Drug. Both drugs have the potential to cause bleeding, monitor closely. Promptly evaluate any signs or symptoms of blood loss. Long-term concomitant treatment with edoxaban and other anticoagulants is not recommended. Short-term coadministration may be needed for patients transitioning to or from edoxaban.</p></li><li>efavirenz<p>efavirenz will increase the level or effect of warfarin by  affecting hepatic enzyme CYP2C9/10 metabolism. Avoid or Use Alternate Drug.</p></li><li>enoxaparin<p>enoxaparin and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug. Additive effects are intended when both drugs are prescribed as indicated for treatment of DVT</p></li><li>eptifibatide<p>warfarin, eptifibatide.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>erythromycin base<p>erythromycin base will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>erythromycin base increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>erythromycin ethylsuccinate<p>erythromycin ethylsuccinate will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>erythromycin ethylsuccinate increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>erythromycin lactobionate<p>erythromycin lactobionate will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>erythromycin lactobionate increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>erythromycin stearate<p>erythromycin stearate will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>erythromycin stearate increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>escitalopram<p>escitalopram increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>estradiol<p>estradiol decreases effects of warfarin by pharmacodynamic antagonism. Contraindicated. Risk of thromboembolic disorders.</p></li><li>estrogens conjugated synthetic<p>estrogens conjugated synthetic decreases effects of warfarin by pharmacodynamic antagonism. Contraindicated. Risk of thromboembolic disorders.</p></li><li>estropipate<p>estropipate decreases effects of warfarin by pharmacodynamic antagonism. Contraindicated. Risk of thromboembolic disorders.</p></li><li>ethinylestradiol<p>ethinylestradiol will increase the level or effect of warfarin by  affecting hepatic enzyme CYP1A2 metabolism. Avoid or Use Alternate Drug. The use of estrogen-containing contraceptives and coumarin derivatives should be avoided to avoid risk of thromboembolic disorders.<span><br><br></span>ethinylestradiol decreases effects of warfarin by pharmacodynamic antagonism. Contraindicated. Risk of thromboembolic disorders.</p></li><li>fenofibrate<p>fenofibrate increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.<span><br><br></span>fenofibrate increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>fenofibrate micronized<p>fenofibrate micronized increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.<span><br><br></span>fenofibrate micronized increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>fenofibric acid<p>fenofibric acid increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.<span><br><br></span>fenofibric acid increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>fluconazole<p>fluconazole increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>fluoxetine<p>fluoxetine increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>fluoxymesterone<p>fluoxymesterone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>fluvoxamine<p>fluvoxamine will increase the level or effect of warfarin by  affecting hepatic enzyme CYP1A2 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>fluvoxamine increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>fondaparinux<p>fondaparinux and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>gemfibrozil<p>gemfibrozil increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.<span><br><br></span>gemfibrozil increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>heparin<p>heparin and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>hexobarbital<p>hexobarbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>imatinib<p>imatinib will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug. Because warfarin is metabolized by CYP2C9 and CYP3A4, patients taking imatinib who require anticoagulation should receive low-molecular weight or standard heparin instead of warfarin.</p></li><li>itraconazole<p>itraconazole will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>itraconazole increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>ketoconazole<p>ketoconazole will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>ketoconazole increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>lepirudin<p>lepirudin and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>levomilnacipran<p>levomilnacipran, warfarin.
Either increases toxicity of the other by pharmacodynamic synergism. Avoid or Use Alternate Drug. SNRIs may further impair platelet activity in patients taking antiplatelet or anticoagulant drugs.</p></li><li>levonorgestrel intrauterine<p>levonorgestrel intrauterine, warfarin.
Either decreases effects of the other by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Risk of thromboembolic disorders.</p></li><li>levonorgestrel oral<p>levonorgestrel oral, warfarin.
Either decreases effects of the other by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Risk of thromboembolic disorders.</p></li><li>levothyroxine<p>levothyroxine increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.</p></li><li>liothyronine<p>liothyronine increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.</p></li><li>mephobarbital<p>mephobarbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>mesterolone<p>mesterolone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>mestranol<p>mestranol decreases effects of warfarin by pharmacodynamic antagonism. Contraindicated. Risk of thromboembolic disorders.</p></li><li>metronidazole<p>metronidazole increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>miconazole vaginal<p>miconazole vaginal increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>milnacipran<p>milnacipran increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>nafcillin<p>nafcillin decreases effects of warfarin by increasing hepatic clearance. Avoid or Use Alternate Drug.</p></li><li>nefazodone<p>nefazodone will increase the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.<span><br><br></span>nefazodone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>nitazoxanide<p>nitazoxanide, warfarin.
Either increases levels of the other by plasma protein binding competition. Avoid or Use Alternate Drug. the active metabolite of nitazoxanide is highly protein bound; avoid use of warfarin with nitazoxanide.</p></li><li>oxandrolone<p>oxandrolone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>oxymetholone<p>oxymetholone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>paroxetine<p>paroxetine increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>pefloxacin<p>pefloxacin will increase the level or effect of warfarin by  affecting hepatic enzyme CYP1A2 metabolism. Avoid or Use Alternate Drug.</p></li><li>pentobarbital<p>pentobarbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>phenindione<p>phenindione and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>phenobarbital<p>phenobarbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>piperacillin<p>piperacillin increases effects of warfarin by anticoagulation. Avoid or Use Alternate Drug. Piperacillin can inhibit platelet aggregation.</p></li><li>posaconazole<p>posaconazole increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>prasugrel<p>warfarin, prasugrel.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>primidone<p>primidone decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>protamine<p>protamine and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>quinine<p>quinine increases effects of warfarin by unknown mechanism. Avoid or Use Alternate Drug.</p></li><li>rifabutin<p>rifabutin will decrease the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.</p></li><li>rifampin<p>rifampin will decrease the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.</p></li><li>ritonavir<p>ritonavir, warfarin. Other (see comment). Avoid or Use Alternate Drug. 
Comment: Variable effect on warfarin levels. Initial frequent monitoring of the INR during co-administration is indicated.</p></li><li>roxithromycin<p>roxithromycin increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>secobarbital<p>secobarbital decreases effects of warfarin by increasing metabolism. Avoid or Use Alternate Drug.</p></li><li>sertraline<p>sertraline increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>st john's wort<p>st john's wort will decrease the level or effect of warfarin by  affecting hepatic/intestinal enzyme CYP3A4 metabolism. Avoid or Use Alternate Drug.</p></li><li>sulfadiazine<p>sulfadiazine increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfadiazine increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>sulfamethoxazole<p>sulfamethoxazole increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfamethoxazole increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>sulfisoxazole<p>sulfisoxazole increases effects of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.<span><br><br></span>sulfisoxazole increases effects of warfarin by plasma protein binding competition. Avoid or Use Alternate Drug.</p></li><li>tamoxifen<p>tamoxifen increases effects of warfarin by unknown mechanism. Avoid or Use Alternate Drug.</p></li><li>tenecteplase<p>warfarin and tenecteplase both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>tesamorelin<p>tesamorelin will decrease the level or effect of warfarin by  altering metabolism. Avoid or Use Alternate Drug. Monitor INR</p></li><li>testosterone<p>testosterone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>testosterone buccal system<p>testosterone buccal system increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>testosterone intranasal<p>testosterone intranasal increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug. Androgens may inhibit warfarin metabolism and/or potentiate anticoagulant effects by affecting the coagulation system.</p></li><li>testosterone topical<p>testosterone topical increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>thyroid desiccated<p>thyroid desiccated increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.</p></li><li>tibolone<p>tibolone increases effects of warfarin by pharmacodynamic synergism. Avoid or Use Alternate Drug.</p></li><li>ticlopidine<p>warfarin, ticlopidine.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>tinzaparin<p>tinzaparin and warfarin both increase  anticoagulation. Avoid or Use Alternate Drug.</p></li><li>tirofiban<p>warfarin, tirofiban.
Either increases effects of the other by pharmacodynamic synergism. Contraindicated. Enhanced risk of hemorrhage.</p></li><li>trazodone<p>trazodone increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>venlafaxine<p>venlafaxine increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li><li>vitamin k1 (phytonadione)<p>vitamin k1 (phytonadione) decreases effects of warfarin by pharmacodynamic antagonism. Avoid or Use Alternate Drug. Monitor for decreased prothrombin time or therapeutic effects.</p></li><li>voriconazole<p>voriconazole increases levels of warfarin by decreasing metabolism. Avoid or Use Alternate Drug.</p></li>